News
-
-
PRESS RELEASE
Strengthening modern hybrid patient care: HAL Allergy and InfectoPharm enter into strategic partnership for digital health applications in ENT
HAL Allergy and InfectoPharm enter strategic partnership for digital health applications in ENT, focusing on patient care and innovative treatment components -
-
PRESS RELEASE
New research results in house dust mite allergy: HAL Allergy completes large Phase III study
HAL Allergy completes large Phase III study on house dust mite allergy, showing significant improvements in allergy symptoms and quality of life, to be shared with authorities and scientific community